RSV clinical trials at UCSF
1 research study open to eligible people
RSV is a virus that causes respiratory infections. UCSF is conducting trials to find out if Azithromycin helps children with severe RSV. The research focuses on better treatments for young patients with serious breathing problems.
Showing trials for
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
open to eligible people ages up to 2 years
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
San Francisco, California and other locations
Our lead scientists for RSV research studies include Matt Zinter, MD James Howard, MD.
Last updated: